Maxigen Biotech Inc Strategic Asset Allocation Index
Maxigen Biotech Inc strategic asset allocation index. Maxigen Biotech Inc (1783) has a Strategic Asset Allocation Index of 33.5% as of December 2022. Strategic assets (PP&E of NT$434.62 Million plus long-term investments of NT$-) total NT$434.62 Million, measured against net assets of NT$1.30 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Maxigen Biotech Inc (1783) balance sheet quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Maxigen Biotech Inc (2015–2022)
Strategic asset allocation index of Maxigen Biotech Inc from 2015 to 2022. This chart shows how Maxigen Biotech Inc's Strategic Asset Allocation Index has evolved across 8 annual periods from 2015 to 2022. As of December 2022, the index stands at 33.5%, representing strategic assets of NT$434.62 Million against net assets of NT$1.30 Billion TWD. Check Maxigen Biotech Inc tangible equity quality to evaluate the tangible quality of the company's equity base.
Maxigen Biotech Inc Strategic Asset Allocation Index by Year (2015–2022)
Maxigen Biotech Inc strategic asset allocation index by year from 2015 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Maxigen Biotech Inc from 2015 to 2022, covering 8 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 1783 company net worth.
| Year | SAAI | Strategic Assets (TWD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 33.5% | NT$434.62 Million | NT$434.62 Million | NT$- | NT$1.30 Billion | ▼ -7.2 pp |
| 2021 | 40.8% | NT$465.45 Million | NT$465.45 Million | NT$- | NT$1.14 Billion | ▼ -15.2 pp |
| 2020 | 56.0% | NT$481.52 Million | NT$481.52 Million | NT$- | NT$860.23 Million | ▼ -3.0 pp |
| 2019 | 59.0% | NT$502.09 Million | NT$502.09 Million | NT$- | NT$851.32 Million | ▲ +0.4 pp |
| 2018 | 58.6% | NT$494.03 Million | NT$494.03 Million | NT$- | NT$842.98 Million | ▼ -4.4 pp |
| 2017 | 63.1% | NT$502.05 Million | NT$502.05 Million | NT$- | NT$796.25 Million | ▼ -1.3 pp |
| 2016 | 64.4% | NT$503.19 Million | NT$503.19 Million | NT$- | NT$781.38 Million | ▲ +10.7 pp |
| 2015 | 53.7% | NT$446.00 Million | NT$446.00 Million | NT$- | NT$829.86 Million | — |